nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—Clobetasol propionate—psoriasis	0.15	0.356	CrCtD
Fluoxymesterone—Hydrocortisone—psoriasis	0.059	0.14	CrCtD
Fluoxymesterone—Dexamethasone—psoriasis	0.0548	0.13	CrCtD
Fluoxymesterone—Betamethasone—psoriasis	0.0548	0.13	CrCtD
Fluoxymesterone—Triamcinolone—psoriasis	0.0535	0.127	CrCtD
Fluoxymesterone—Prednisolone—psoriasis	0.0496	0.118	CrCtD
Fluoxymesterone—NR3C1—Clobetasol propionate—psoriasis	0.0449	0.193	CbGbCtD
Fluoxymesterone—NR3C1—Fluocinonide—psoriasis	0.034	0.146	CbGbCtD
Fluoxymesterone—NR3C1—Beclomethasone—psoriasis	0.034	0.146	CbGbCtD
Fluoxymesterone—NR3C1—Fluocinolone Acetonide—psoriasis	0.034	0.146	CbGbCtD
Fluoxymesterone—SHBG—Hydrocortisone—psoriasis	0.0204	0.0878	CbGbCtD
Fluoxymesterone—NR3C1—Triamcinolone—psoriasis	0.0136	0.0583	CbGbCtD
Fluoxymesterone—NR3C1—Betamethasone—psoriasis	0.0116	0.05	CbGbCtD
Fluoxymesterone—NR3C1—Prednisolone—psoriasis	0.0115	0.0493	CbGbCtD
Fluoxymesterone—NR3C1—Hydrocortisone—psoriasis	0.0109	0.0467	CbGbCtD
Fluoxymesterone—NR3C1—Prednisone—psoriasis	0.0108	0.0466	CbGbCtD
Fluoxymesterone—NR3C1—Dexamethasone—psoriasis	0.00676	0.0291	CbGbCtD
Fluoxymesterone—Amcinonide—Clobetasol propionate—psoriasis	0.00429	0.0143	CrCrCtD
Fluoxymesterone—Fludrocortisone—Clobetasol propionate—psoriasis	0.00418	0.014	CrCrCtD
Fluoxymesterone—Hydrocortamate—Beclomethasone—psoriasis	0.00397	0.0133	CrCrCtD
Fluoxymesterone—Desoximetasone—Clobetasol propionate—psoriasis	0.00397	0.0133	CrCrCtD
Fluoxymesterone—Triamcinolone—Clobetasol propionate—psoriasis	0.00388	0.013	CrCrCtD
Fluoxymesterone—Loteprednol—Clobetasol propionate—psoriasis	0.00388	0.013	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Clobetasol propionate—psoriasis	0.00388	0.013	CrCrCtD
Fluoxymesterone—Mometasone—Clobetasol propionate—psoriasis	0.00388	0.013	CrCrCtD
Fluoxymesterone—Fluorometholone—Clobetasol propionate—psoriasis	0.00388	0.013	CrCrCtD
Fluoxymesterone—Dexamethasone—Clobetasol propionate—psoriasis	0.00379	0.0127	CrCrCtD
Fluoxymesterone—Betamethasone—Clobetasol propionate—psoriasis	0.00379	0.0127	CrCrCtD
Fluoxymesterone—Prednisolone—Clobetasol propionate—psoriasis	0.00355	0.0119	CrCrCtD
Fluoxymesterone—Eplerenone—Hydrocortisone—psoriasis	0.00351	0.0117	CrCrCtD
Fluoxymesterone—Amcinonide—Beclomethasone—psoriasis	0.00344	0.0115	CrCrCtD
Fluoxymesterone—Amcinonide—Fluocinonide—psoriasis	0.00344	0.0115	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Fluocinonide—psoriasis	0.00335	0.0112	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Beclomethasone—psoriasis	0.00335	0.0112	CrCrCtD
Fluoxymesterone—Amcinonide—Fluocinolone Acetonide—psoriasis	0.00334	0.0112	CrCrCtD
Fluoxymesterone—Fludrocortisone—Fluocinolone Acetonide—psoriasis	0.00325	0.0109	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Fluocinolone Acetonide—psoriasis	0.00325	0.0109	CrCrCtD
Fluoxymesterone—Desoximetasone—Fluocinonide—psoriasis	0.00318	0.0106	CrCrCtD
Fluoxymesterone—Desoximetasone—Beclomethasone—psoriasis	0.00318	0.0106	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Beclomethasone—psoriasis	0.00311	0.0104	CrCrCtD
Fluoxymesterone—Fluorometholone—Fluocinonide—psoriasis	0.00311	0.0104	CrCrCtD
Fluoxymesterone—Loteprednol—Beclomethasone—psoriasis	0.00311	0.0104	CrCrCtD
Fluoxymesterone—Fluorometholone—Beclomethasone—psoriasis	0.00311	0.0104	CrCrCtD
Fluoxymesterone—Triamcinolone—Fluocinonide—psoriasis	0.00311	0.0104	CrCrCtD
Fluoxymesterone—Mometasone—Fluocinonide—psoriasis	0.00311	0.0104	CrCrCtD
Fluoxymesterone—Triamcinolone—Beclomethasone—psoriasis	0.00311	0.0104	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Fluocinonide—psoriasis	0.00311	0.0104	CrCrCtD
Fluoxymesterone—Mometasone—Beclomethasone—psoriasis	0.00311	0.0104	CrCrCtD
Fluoxymesterone—Desoximetasone—Fluocinolone Acetonide—psoriasis	0.00309	0.0103	CrCrCtD
Fluoxymesterone—Dexamethasone—Beclomethasone—psoriasis	0.00304	0.0101	CrCrCtD
Fluoxymesterone—Betamethasone—Fluocinonide—psoriasis	0.00304	0.0101	CrCrCtD
Fluoxymesterone—Betamethasone—Beclomethasone—psoriasis	0.00304	0.0101	CrCrCtD
Fluoxymesterone—Dexamethasone—Fluocinonide—psoriasis	0.00304	0.0101	CrCrCtD
Fluoxymesterone—Triamcinolone—Fluocinolone Acetonide—psoriasis	0.00302	0.0101	CrCrCtD
Fluoxymesterone—Mometasone—Fluocinolone Acetonide—psoriasis	0.00302	0.0101	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Fluocinolone Acetonide—psoriasis	0.00302	0.0101	CrCrCtD
Fluoxymesterone—Fluorometholone—Fluocinolone Acetonide—psoriasis	0.00302	0.0101	CrCrCtD
Fluoxymesterone—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.00295	0.00986	CrCrCtD
Fluoxymesterone—Betamethasone—Fluocinolone Acetonide—psoriasis	0.00295	0.00986	CrCrCtD
Fluoxymesterone—Prednisolone—Beclomethasone—psoriasis	0.00284	0.0095	CrCrCtD
Fluoxymesterone—Dydrogesterone—Hydrocortisone—psoriasis	0.00279	0.00932	CrCrCtD
Fluoxymesterone—Prednisolone—Fluocinolone Acetonide—psoriasis	0.00276	0.00924	CrCrCtD
Fluoxymesterone—Potassium Canrenoate—Hydrocortisone—psoriasis	0.00266	0.00888	CrCrCtD
Fluoxymesterone—Spironolactone—Hydrocortisone—psoriasis	0.00266	0.00888	CrCrCtD
Fluoxymesterone—Megestrol acetate—Hydrocortisone—psoriasis	0.00243	0.00812	CrCrCtD
Fluoxymesterone—Potassium Canrenoate—Prednisone—psoriasis	0.00229	0.00764	CrCrCtD
Fluoxymesterone—Danazol—Hydrocortisone—psoriasis	0.00224	0.0075	CrCrCtD
Fluoxymesterone—Potassium Canrenoate—Prednisolone—psoriasis	0.00223	0.00746	CrCrCtD
Fluoxymesterone—Medroxyprogesterone Acetate—Hydrocortisone—psoriasis	0.00216	0.00722	CrCrCtD
Fluoxymesterone—Norethindrone—Hydrocortisone—psoriasis	0.00195	0.00652	CrCrCtD
Fluoxymesterone—Hydrocortamate—Hydrocortisone—psoriasis	0.00195	0.00652	CrCrCtD
Fluoxymesterone—Danazol—Prednisone—psoriasis	0.00193	0.00645	CrCrCtD
Fluoxymesterone—Cortisone acetate—Hydrocortisone—psoriasis	0.00189	0.00632	CrCrCtD
Fluoxymesterone—Testolactone—Betamethasone—psoriasis	0.0017	0.00569	CrCrCtD
Fluoxymesterone—Testolactone—Dexamethasone—psoriasis	0.0017	0.00569	CrCrCtD
Fluoxymesterone—Hydrocortamate—Prednisone—psoriasis	0.00168	0.00561	CrCrCtD
Fluoxymesterone—Testolactone—Triamcinolone—psoriasis	0.00166	0.00556	CrCrCtD
Fluoxymesterone—Progesterone—Hydrocortisone—psoriasis	0.00164	0.00549	CrCrCtD
Fluoxymesterone—Testosterone Propionate—Hydrocortisone—psoriasis	0.00164	0.00549	CrCrCtD
Fluoxymesterone—Fludrocortisone—Hydrocortisone—psoriasis	0.00164	0.00549	CrCrCtD
Fluoxymesterone—Hydrocortamate—Prednisolone—psoriasis	0.00164	0.00548	CrCrCtD
Fluoxymesterone—Cortisone acetate—Prednisone—psoriasis	0.00163	0.00544	CrCrCtD
Fluoxymesterone—Methyltestosterone—Hydrocortisone—psoriasis	0.0016	0.00535	CrCrCtD
Fluoxymesterone—Cortisone acetate—Prednisolone—psoriasis	0.00159	0.00531	CrCrCtD
Fluoxymesterone—Testolactone—Prednisone—psoriasis	0.00158	0.00528	CrCrCtD
Fluoxymesterone—Amcinonide—Betamethasone—psoriasis	0.00157	0.00523	CrCrCtD
Fluoxymesterone—Amcinonide—Dexamethasone—psoriasis	0.00157	0.00523	CrCrCtD
Fluoxymesterone—Desoximetasone—Hydrocortisone—psoriasis	0.00156	0.00522	CrCrCtD
Fluoxymesterone—Testolactone—Prednisolone—psoriasis	0.00154	0.00515	CrCrCtD
Fluoxymesterone—Amcinonide—Triamcinolone—psoriasis	0.00153	0.00511	CrCrCtD
Fluoxymesterone—Fluorometholone—Hydrocortisone—psoriasis	0.00153	0.0051	CrCrCtD
Fluoxymesterone—Triamcinolone—Hydrocortisone—psoriasis	0.00153	0.0051	CrCrCtD
Fluoxymesterone—Mometasone—Hydrocortisone—psoriasis	0.00153	0.0051	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Hydrocortisone—psoriasis	0.00153	0.0051	CrCrCtD
Fluoxymesterone—Loteprednol—Hydrocortisone—psoriasis	0.00153	0.0051	CrCrCtD
Fluoxymesterone—Fludrocortisone—Betamethasone—psoriasis	0.00153	0.0051	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Dexamethasone—psoriasis	0.00153	0.0051	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Betamethasone—psoriasis	0.00153	0.0051	CrCrCtD
Fluoxymesterone—Fludrocortisone—Dexamethasone—psoriasis	0.00153	0.0051	CrCrCtD
Fluoxymesterone—Dexamethasone—Hydrocortisone—psoriasis	0.00149	0.00498	CrCrCtD
Fluoxymesterone—Betamethasone—Hydrocortisone—psoriasis	0.00149	0.00498	CrCrCtD
Fluoxymesterone—Fludrocortisone—Triamcinolone—psoriasis	0.00149	0.00498	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Triamcinolone—psoriasis	0.00149	0.00498	CrCrCtD
Fluoxymesterone—Amcinonide—Prednisone—psoriasis	0.00145	0.00485	CrCrCtD
Fluoxymesterone—Desoximetasone—Betamethasone—psoriasis	0.00145	0.00485	CrCrCtD
Fluoxymesterone—Desoximetasone—Dexamethasone—psoriasis	0.00145	0.00485	CrCrCtD
Fluoxymesterone—Oligospermia—Hydroxyurea—psoriasis	0.00143	0.0496	CcSEcCtD
Fluoxymesterone—Testosterone—Hydrocortisone—psoriasis	0.00143	0.00476	CrCrCtD
Fluoxymesterone—Desoximetasone—Triamcinolone—psoriasis	0.00142	0.00474	CrCrCtD
Fluoxymesterone—Amcinonide—Prednisolone—psoriasis	0.00142	0.00474	CrCrCtD
Fluoxymesterone—Mometasone—Dexamethasone—psoriasis	0.00142	0.00473	CrCrCtD
Fluoxymesterone—Loteprednol—Dexamethasone—psoriasis	0.00142	0.00473	CrCrCtD
Fluoxymesterone—Loteprednol—Betamethasone—psoriasis	0.00142	0.00473	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Betamethasone—psoriasis	0.00142	0.00473	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Dexamethasone—psoriasis	0.00142	0.00473	CrCrCtD
Fluoxymesterone—Mometasone—Betamethasone—psoriasis	0.00142	0.00473	CrCrCtD
Fluoxymesterone—Triamcinolone—Dexamethasone—psoriasis	0.00142	0.00473	CrCrCtD
Fluoxymesterone—Triamcinolone—Betamethasone—psoriasis	0.00142	0.00473	CrCrCtD
Fluoxymesterone—Fluorometholone—Betamethasone—psoriasis	0.00142	0.00473	CrCrCtD
Fluoxymesterone—Fluorometholone—Dexamethasone—psoriasis	0.00142	0.00473	CrCrCtD
Fluoxymesterone—Fludrocortisone—Prednisone—psoriasis	0.00141	0.00473	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Prednisone—psoriasis	0.00141	0.00473	CrCrCtD
Fluoxymesterone—Prednisolone—Hydrocortisone—psoriasis	0.0014	0.00466	CrCrCtD
Fluoxymesterone—Dexamethasone—Betamethasone—psoriasis	0.00138	0.00463	CrCrCtD
Fluoxymesterone—Betamethasone—Dexamethasone—psoriasis	0.00138	0.00463	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Triamcinolone—psoriasis	0.00138	0.00463	CrCrCtD
Fluoxymesterone—Loteprednol—Triamcinolone—psoriasis	0.00138	0.00463	CrCrCtD
Fluoxymesterone—Mometasone—Triamcinolone—psoriasis	0.00138	0.00463	CrCrCtD
Fluoxymesterone—Fluorometholone—Triamcinolone—psoriasis	0.00138	0.00463	CrCrCtD
Fluoxymesterone—Fludrocortisone—Prednisolone—psoriasis	0.00138	0.00461	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Prednisolone—psoriasis	0.00138	0.00461	CrCrCtD
Fluoxymesterone—Progesterone—Prednisolone—psoriasis	0.00138	0.00461	CrCrCtD
Fluoxymesterone—Methyltestosterone—Prednisone—psoriasis	0.00138	0.00461	CrCrCtD
Fluoxymesterone—Dexamethasone—Triamcinolone—psoriasis	0.00135	0.00452	CrCrCtD
Fluoxymesterone—Betamethasone—Triamcinolone—psoriasis	0.00135	0.00452	CrCrCtD
Fluoxymesterone—Methyltestosterone—Prednisolone—psoriasis	0.00135	0.0045	CrCrCtD
Fluoxymesterone—Desoximetasone—Prednisone—psoriasis	0.00135	0.0045	CrCrCtD
Fluoxymesterone—Loteprednol—Prednisone—psoriasis	0.00131	0.00439	CrCrCtD
Fluoxymesterone—Fluorometholone—Prednisone—psoriasis	0.00131	0.00439	CrCrCtD
Fluoxymesterone—Mometasone—Prednisone—psoriasis	0.00131	0.00439	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Prednisone—psoriasis	0.00131	0.00439	CrCrCtD
Fluoxymesterone—Triamcinolone—Prednisone—psoriasis	0.00131	0.00439	CrCrCtD
Fluoxymesterone—Desoximetasone—Prednisolone—psoriasis	0.00131	0.00439	CrCrCtD
Fluoxymesterone—Prednisolone—Betamethasone—psoriasis	0.0013	0.00433	CrCrCtD
Fluoxymesterone—Prednisolone—Dexamethasone—psoriasis	0.0013	0.00433	CrCrCtD
Fluoxymesterone—Betamethasone—Prednisone—psoriasis	0.00128	0.00429	CrCrCtD
Fluoxymesterone—Dexamethasone—Prednisone—psoriasis	0.00128	0.00429	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Prednisolone—psoriasis	0.00128	0.00429	CrCrCtD
Fluoxymesterone—Mometasone—Prednisolone—psoriasis	0.00128	0.00429	CrCrCtD
Fluoxymesterone—Triamcinolone—Prednisolone—psoriasis	0.00128	0.00429	CrCrCtD
Fluoxymesterone—Fluorometholone—Prednisolone—psoriasis	0.00128	0.00429	CrCrCtD
Fluoxymesterone—Loteprednol—Prednisolone—psoriasis	0.00128	0.00429	CrCrCtD
Fluoxymesterone—Prednisolone—Triamcinolone—psoriasis	0.00127	0.00423	CrCrCtD
Fluoxymesterone—Dexamethasone—Prednisolone—psoriasis	0.00125	0.00419	CrCrCtD
Fluoxymesterone—Betamethasone—Prednisolone—psoriasis	0.00125	0.00419	CrCrCtD
Fluoxymesterone—Hydrocortisone—Dexamethasone—psoriasis	0.00124	0.00416	CrCrCtD
Fluoxymesterone—Hydrocortisone—Betamethasone—psoriasis	0.00124	0.00416	CrCrCtD
Fluoxymesterone—Hydrocortisone—Triamcinolone—psoriasis	0.00122	0.00406	CrCrCtD
Fluoxymesterone—Prednisolone—Prednisone—psoriasis	0.0012	0.00402	CrCrCtD
Fluoxymesterone—Testosterone—Prednisolone—psoriasis	0.0012	0.004	CrCrCtD
Fluoxymesterone—Hydrocortisone—Prednisone—psoriasis	0.00115	0.00385	CrCrCtD
Fluoxymesterone—Polycythaemia—Mycophenolic acid—psoriasis	0.00115	0.0399	CcSEcCtD
Fluoxymesterone—Hydrocortisone—Prednisolone—psoriasis	0.00113	0.00376	CrCrCtD
Fluoxymesterone—Azoospermia—Hydroxyurea—psoriasis	0.00111	0.0386	CcSEcCtD
Fluoxymesterone—Polycythaemia—Mycophenolate mofetil—psoriasis	0.000905	0.0315	CcSEcCtD
Fluoxymesterone—Polycythaemia—Prednisone—psoriasis	0.000613	0.0213	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Acitretin—psoriasis	0.000558	0.0194	CcSEcCtD
Fluoxymesterone—Oligospermia—Methotrexate—psoriasis	0.000534	0.0186	CcSEcCtD
Fluoxymesterone—Hirsutism—Mycophenolic acid—psoriasis	0.000431	0.015	CcSEcCtD
Fluoxymesterone—Azoospermia—Methotrexate—psoriasis	0.000416	0.0145	CcSEcCtD
Fluoxymesterone—Haemoglobin—Tazarotene—psoriasis	0.000401	0.014	CcSEcCtD
Fluoxymesterone—Haemorrhage—Tazarotene—psoriasis	0.000399	0.0139	CcSEcCtD
Fluoxymesterone—Hirsutism—Cyclosporine—psoriasis	0.000348	0.0121	CcSEcCtD
Fluoxymesterone—Paraesthesia—Calcipotriol—psoriasis	0.000346	0.012	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Hydroxyurea—psoriasis	0.00034	0.0118	CcSEcCtD
Fluoxymesterone—Hirsutism—Mycophenolate mofetil—psoriasis	0.00034	0.0118	CcSEcCtD
Fluoxymesterone—Libido decreased—Calcitriol—psoriasis	0.000335	0.0116	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Prednisolone—psoriasis	0.000333	0.0116	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Hydrocortisone—psoriasis	0.000325	0.0113	CcSEcCtD
Fluoxymesterone—Coagulopathy—Mycophenolic acid—psoriasis	0.000322	0.0112	CcSEcCtD
Fluoxymesterone—Hirsutism—Prednisolone—psoriasis	0.000317	0.011	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—DDX58—psoriasis	0.000314	0.0177	CbGpPWpGaD
Fluoxymesterone—Hirsutism—Hydrocortisone—psoriasis	0.00031	0.0108	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Calcitriol—psoriasis	0.000308	0.0107	CcSEcCtD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—TYK2—psoriasis	0.000308	0.0173	CbGpPWpGaD
Fluoxymesterone—Menstruation irregular—Triamcinolone—psoriasis	0.000306	0.0106	CcSEcCtD
Fluoxymesterone—Alopecia—Clobetasol propionate—psoriasis	0.000299	0.0104	CcSEcCtD
Fluoxymesterone—Libido decreased—Acitretin—psoriasis	0.000298	0.0104	CcSEcCtD
Fluoxymesterone—Hirsutism—Triamcinolone—psoriasis	0.000292	0.0101	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Mycophenolate mofetil—psoriasis	0.00029	0.0101	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Mycophenolic acid—psoriasis	0.000285	0.00991	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Calcipotriol—psoriasis	0.000284	0.00986	CcSEcCtD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—ZMIZ1—psoriasis	0.000281	0.0158	CbGpPWpGaD
Fluoxymesterone—Menstruation irregular—Betamethasone—psoriasis	0.000278	0.00966	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Dexamethasone—psoriasis	0.000278	0.00966	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Acitretin—psoriasis	0.000274	0.00953	CcSEcCtD
Fluoxymesterone—Hirsutism—Betamethasone—psoriasis	0.000265	0.0092	CcSEcCtD
Fluoxymesterone—Hirsutism—Dexamethasone—psoriasis	0.000265	0.0092	CcSEcCtD
Fluoxymesterone—PRLR—Adipogenesis—SOCS1—psoriasis	0.000263	0.0148	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL23A—psoriasis	0.000261	0.0147	CbGpPWpGaD
Fluoxymesterone—Coagulopathy—Cyclosporine—psoriasis	0.00026	0.00905	CcSEcCtD
Fluoxymesterone—Coagulopathy—Mycophenolate mofetil—psoriasis	0.000254	0.00882	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Prednisone—psoriasis	0.000242	0.00841	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Cyclosporine—psoriasis	0.00023	0.00802	CcSEcCtD
Fluoxymesterone—Hirsutism—Prednisone—psoriasis	0.00023	0.00801	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—KIR2DS1—psoriasis	0.000228	0.0128	CbGpPWpGaD
Fluoxymesterone—Amenorrhoea—Mycophenolate mofetil—psoriasis	0.000225	0.00782	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Mycophenolate mofetil—psoriasis	0.000225	0.00782	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Beclomethasone—psoriasis	0.000219	0.00762	CcSEcCtD
Fluoxymesterone—Paraesthesia—Clobetasol propionate—psoriasis	0.000216	0.00751	CcSEcCtD
Fluoxymesterone—Haemoglobin—Calcitriol—psoriasis	0.000216	0.00751	CcSEcCtD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—STAT3—psoriasis	0.000216	0.0121	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Calcitriol—psoriasis	0.000215	0.00747	CcSEcCtD
Fluoxymesterone—AR—Androgen receptor signaling pathway—ZMIZ1—psoriasis	0.000208	0.0117	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—REL—psoriasis	0.000206	0.0116	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HLA-C—psoriasis	0.000205	0.0116	CbGpPWpGaD
Fluoxymesterone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	0.000205	0.0115	CbGpPWpGaD
Fluoxymesterone—Amenorrhoea—Hydrocortisone—psoriasis	0.000205	0.00712	CcSEcCtD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—CARM1—psoriasis	0.000203	0.0114	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—LEP—psoriasis	0.000194	0.0109	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Acitretin—psoriasis	0.000192	0.00668	CcSEcCtD
Fluoxymesterone—Haemorrhage—Acitretin—psoriasis	0.000191	0.00665	CcSEcCtD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—TGFA—psoriasis	0.000188	0.0106	CbGpPWpGaD
Fluoxymesterone—Gynaecomastia—Cyclosporine—psoriasis	0.000181	0.0063	CcSEcCtD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CARM1—psoriasis	0.000181	0.0102	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Clobetasol propionate—psoriasis	0.000177	0.00616	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Mycophenolate mofetil—psoriasis	0.000177	0.00615	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Betamethasone—psoriasis	0.000175	0.00609	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Dexamethasone—psoriasis	0.000175	0.00609	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HLA-E—psoriasis	0.00017	0.00959	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.00017	0.00956	CbGpPWpGaD
Fluoxymesterone—Alopecia—Acitretin—psoriasis	0.000169	0.00588	CcSEcCtD
Fluoxymesterone—PRLR—Adipogenesis—PPARG—psoriasis	0.000169	0.00951	CbGpPWpGaD
Fluoxymesterone—Alopecia—Fluocinolone Acetonide—psoriasis	0.000168	0.00586	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Fluocinonide—psoriasis	0.00016	0.00556	CcSEcCtD
Fluoxymesterone—Anxiety—Calcitriol—psoriasis	0.000159	0.00552	CcSEcCtD
Fluoxymesterone—Libido decreased—Cyclosporine—psoriasis	0.000159	0.00551	CcSEcCtD
Fluoxymesterone—AR—Nuclear Receptors—VDR—psoriasis	0.000158	0.0089	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—REL—psoriasis	0.000156	0.00879	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—CARM1—psoriasis	0.000154	0.00866	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Calcitriol—psoriasis	0.000153	0.00531	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Prednisone—psoriasis	0.000152	0.0053	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Cyclosporine—psoriasis	0.000152	0.00528	CcSEcCtD
Fluoxymesterone—Haemoglobin—Hydroxyurea—psoriasis	0.000151	0.00525	CcSEcCtD
Fluoxymesterone—Headache—Clobetasol propionate—psoriasis	0.000151	0.00524	CcSEcCtD
Fluoxymesterone—Haemorrhage—Hydroxyurea—psoriasis	0.00015	0.00522	CcSEcCtD
Fluoxymesterone—NR3C1—Circadian Clock—CARM1—psoriasis	0.000149	0.00841	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—LEP—psoriasis	0.000148	0.00837	CbGpPWpGaD
Fluoxymesterone—Disturbance in sexual arousal—Cyclosporine—psoriasis	0.000146	0.00507	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—SOCS1—psoriasis	0.000142	0.00801	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen Receptor Pathway—JUN—psoriasis	0.000142	0.00799	CbGpPWpGaD
Fluoxymesterone—Anxiety—Acitretin—psoriasis	0.000141	0.00491	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Prednisolone—psoriasis	0.000138	0.00481	CcSEcCtD
Fluoxymesterone—Headache—Beclomethasone—psoriasis	0.000137	0.00477	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000136	0.00767	CbGpPWpGaD
Fluoxymesterone—Headache—Fluocinonide—psoriasis	0.000136	0.00473	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Hydrocortisone—psoriasis	0.000135	0.00469	CcSEcCtD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CARM1—psoriasis	0.000134	0.00754	CbGpPWpGaD
Fluoxymesterone—Alopecia—Hydroxyurea—psoriasis	0.000133	0.00461	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.000131	0.00737	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—TYK2—psoriasis	0.000131	0.00736	CbGpPWpGaD
Fluoxymesterone—Nausea—Beclomethasone—psoriasis	0.00013	0.00452	CcSEcCtD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—psoriasis	0.000129	0.00729	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.000129	0.00726	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Triamcinolone—psoriasis	0.000127	0.00442	CcSEcCtD
Fluoxymesterone—Haemoglobin—Mycophenolic acid—psoriasis	0.000126	0.00439	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Methoxsalen—psoriasis	0.000126	0.00439	CcSEcCtD
Fluoxymesterone—Haemorrhage—Mycophenolic acid—psoriasis	0.000126	0.00437	CcSEcCtD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000125	0.00703	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000123	0.00691	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Acitretin—psoriasis	0.000122	0.00424	CcSEcCtD
Fluoxymesterone—ESR1—Nuclear Receptors—VDR—psoriasis	0.000122	0.00685	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HLA-B—psoriasis	0.000121	0.00683	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—REL—psoriasis	0.00012	0.00676	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptors—VDR—psoriasis	0.00012	0.00675	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ERAP1—psoriasis	0.000117	0.00657	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Dexamethasone—psoriasis	0.000115	0.00401	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Betamethasone—psoriasis	0.000115	0.00401	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Calcitriol—psoriasis	0.000112	0.00391	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HLA-A—psoriasis	0.000112	0.00633	CbGpPWpGaD
Fluoxymesterone—Alopecia—Mycophenolic acid—psoriasis	0.000111	0.00386	CcSEcCtD
Fluoxymesterone—AR—Nuclear Receptors—PPARG—psoriasis	0.00011	0.0062	CbGpPWpGaD
Fluoxymesterone—Headache—Methoxsalen—psoriasis	0.000107	0.00373	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—HCAR2—psoriasis	0.000105	0.00591	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000105	0.00591	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—STAT3—psoriasis	0.000104	0.00584	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—DDX58—psoriasis	0.000103	0.00579	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HLA-DRB1—psoriasis	0.000103	0.00578	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Cyclosporine—psoriasis	0.000102	0.00355	CcSEcCtD
Fluoxymesterone—Nausea—Methoxsalen—psoriasis	0.000102	0.00354	CcSEcCtD
Fluoxymesterone—Haemorrhage—Cyclosporine—psoriasis	0.000102	0.00354	CcSEcCtD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL13—psoriasis	0.000101	0.00567	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.0001	0.00566	CbGpPWpGaD
Fluoxymesterone—Gynaecomastia—Methotrexate—psoriasis	0.0001	0.00348	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Acitretin—psoriasis	0.0001	0.00348	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Fluocinolone Acetonide—psoriasis	9.98e-05	0.00347	CcSEcCtD
Fluoxymesterone—Haemoglobin—Mycophenolate mofetil—psoriasis	9.97e-05	0.00347	CcSEcCtD
Fluoxymesterone—Haemorrhage—Mycophenolate mofetil—psoriasis	9.92e-05	0.00345	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—ICAM1—psoriasis	9.85e-05	0.00555	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	9.69e-05	0.00546	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—VDR—psoriasis	9.61e-05	0.00542	CbGpPWpGaD
Fluoxymesterone—Headache—Calcitriol—psoriasis	9.56e-05	0.00333	CcSEcCtD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—VDR—psoriasis	9.46e-05	0.00533	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	9.45e-05	0.00532	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Prednisolone—psoriasis	9.3e-05	0.00323	CcSEcCtD
Fluoxymesterone—Anxiety—Mycophenolic acid—psoriasis	9.28e-05	0.00323	CcSEcCtD
Fluoxymesterone—Haemorrhage—Prednisolone—psoriasis	9.25e-05	0.00322	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—TAGAP—psoriasis	9.1e-05	0.00513	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Hydrocortisone—psoriasis	9.08e-05	0.00316	CcSEcCtD
Fluoxymesterone—Nausea—Calcitriol—psoriasis	9.07e-05	0.00315	CcSEcCtD
Fluoxymesterone—Haemorrhage—Hydrocortisone—psoriasis	9.04e-05	0.00314	CcSEcCtD
Fluoxymesterone—Alopecia—Cyclosporine—psoriasis	8.99e-05	0.00313	CcSEcCtD
Fluoxymesterone—ESR1—Estrogen signaling pathway—JUN—psoriasis	8.99e-05	0.00506	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—TNF—psoriasis	8.96e-05	0.00505	CbGpPWpGaD
Fluoxymesterone—Alopecia—Mycophenolate mofetil—psoriasis	8.77e-05	0.00305	CcSEcCtD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—PPARG—psoriasis	8.7e-05	0.0049	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—NFKB1—psoriasis	8.65e-05	0.00487	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	8.62e-05	0.00486	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Triamcinolone—psoriasis	8.55e-05	0.00297	CcSEcCtD
Fluoxymesterone—Haemorrhage—Triamcinolone—psoriasis	8.51e-05	0.00296	CcSEcCtD
Fluoxymesterone—Headache—Acitretin—psoriasis	8.51e-05	0.00296	CcSEcCtD
Fluoxymesterone—Headache—Fluocinolone Acetonide—psoriasis	8.48e-05	0.00295	CcSEcCtD
Fluoxymesterone—ESR1—Nuclear Receptors—PPARG—psoriasis	8.48e-05	0.00478	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Methotrexate—psoriasis	8.39e-05	0.00292	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	8.38e-05	0.00472	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptors—PPARG—psoriasis	8.35e-05	0.00471	CbGpPWpGaD
Fluoxymesterone—Nausea—Acitretin—psoriasis	8.07e-05	0.00281	CcSEcCtD
Fluoxymesterone—Nausea—Fluocinolone Acetonide—psoriasis	8.04e-05	0.0028	CcSEcCtD
Fluoxymesterone—Paraesthesia—Mycophenolic acid—psoriasis	8.02e-05	0.00279	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—TYK2—psoriasis	8.01e-05	0.00451	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL13—psoriasis	7.93e-05	0.00447	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Hydroxyurea—psoriasis	7.86e-05	0.00273	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—ITGAL—psoriasis	7.78e-05	0.00438	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Betamethasone—psoriasis	7.76e-05	0.0027	CcSEcCtD
Fluoxymesterone—Haemoglobin—Dexamethasone—psoriasis	7.76e-05	0.0027	CcSEcCtD
Fluoxymesterone—Haemorrhage—Betamethasone—psoriasis	7.72e-05	0.00269	CcSEcCtD
Fluoxymesterone—Haemorrhage—Dexamethasone—psoriasis	7.72e-05	0.00269	CcSEcCtD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—RUNX3—psoriasis	7.62e-05	0.0043	CbGpPWpGaD
Fluoxymesterone—Anxiety—Cyclosporine—psoriasis	7.51e-05	0.00261	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IFNG—psoriasis	7.5e-05	0.00422	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—CD4—psoriasis	7.36e-05	0.00415	CbGpPWpGaD
Fluoxymesterone—Anxiety—Mycophenolate mofetil—psoriasis	7.33e-05	0.00255	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.28e-05	0.0041	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—REL—psoriasis	7.28e-05	0.0041	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL10—psoriasis	7.26e-05	0.00409	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—IL6—psoriasis	7.23e-05	0.00408	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Cyclosporine—psoriasis	7.23e-05	0.00251	CcSEcCtD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL10—psoriasis	7.15e-05	0.00403	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—PCNA—psoriasis	7.11e-05	0.00401	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IFIH1—psoriasis	7.06e-05	0.00398	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL4—psoriasis	7.06e-05	0.00398	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Mycophenolate mofetil—psoriasis	7.05e-05	0.00245	CcSEcCtD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL4—psoriasis	6.95e-05	0.00392	CbGpPWpGaD
Fluoxymesterone—AR—FOXA1 transcription factor network—JUN—psoriasis	6.94e-05	0.00391	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—TNF—psoriasis	6.87e-05	0.00387	CbGpPWpGaD
Fluoxymesterone—Alopecia—Betamethasone—psoriasis	6.82e-05	0.00237	CcSEcCtD
Fluoxymesterone—Alopecia—Dexamethasone—psoriasis	6.82e-05	0.00237	CcSEcCtD
Fluoxymesterone—Haemoglobin—Prednisone—psoriasis	6.76e-05	0.00235	CcSEcCtD
Fluoxymesterone—Haemorrhage—Prednisone—psoriasis	6.72e-05	0.00234	CcSEcCtD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—PPARG—psoriasis	6.7e-05	0.00378	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HLA-C—psoriasis	6.7e-05	0.00377	CbGpPWpGaD
Fluoxymesterone—Headache—Hydroxyurea—psoriasis	6.68e-05	0.00232	CcSEcCtD
Fluoxymesterone—Anxiety—Hydrocortisone—psoriasis	6.68e-05	0.00232	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	6.64e-05	0.00374	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—TNFAIP3—psoriasis	6.62e-05	0.00373	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—PPARG—psoriasis	6.6e-05	0.00372	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Prednisolone—psoriasis	6.57e-05	0.00229	CcSEcCtD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	6.54e-05	0.00368	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Cyclosporine—psoriasis	6.49e-05	0.00226	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	6.46e-05	0.00364	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	6.42e-05	0.00362	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Hydrocortisone—psoriasis	6.42e-05	0.00223	CcSEcCtD
Fluoxymesterone—ESR1—AP-1 transcription factor network—HLA-A—psoriasis	6.39e-05	0.0036	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—IL6—psoriasis	6.38e-05	0.0036	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—NOS2—psoriasis	6.38e-05	0.0036	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	6.36e-05	0.00358	CbGpPWpGaD
Fluoxymesterone—Nausea—Hydroxyurea—psoriasis	6.33e-05	0.0022	CcSEcCtD
Fluoxymesterone—Paraesthesia—Mycophenolate mofetil—psoriasis	6.33e-05	0.0022	CcSEcCtD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—HLA-A—psoriasis	6.3e-05	0.00355	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—NFKB1—psoriasis	6.24e-05	0.00352	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL4—psoriasis	6.13e-05	0.00345	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Triamcinolone—psoriasis	6.05e-05	0.0021	CcSEcCtD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL13—psoriasis	6.02e-05	0.00339	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—JUN—psoriasis	5.98e-05	0.00337	CbGpPWpGaD
Fluoxymesterone—Alopecia—Prednisone—psoriasis	5.94e-05	0.00207	CcSEcCtD
Fluoxymesterone—Paraesthesia—Prednisolone—psoriasis	5.9e-05	0.00205	CcSEcCtD
Fluoxymesterone—Paraesthesia—Hydrocortisone—psoriasis	5.77e-05	0.00201	CcSEcCtD
Fluoxymesterone—Anxiety—Dexamethasone—psoriasis	5.7e-05	0.00198	CcSEcCtD
Fluoxymesterone—Anxiety—Betamethasone—psoriasis	5.7e-05	0.00198	CcSEcCtD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—STAT3—psoriasis	5.7e-05	0.00321	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—LEP—psoriasis	5.65e-05	0.00318	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Methotrexate—psoriasis	5.65e-05	0.00196	CcSEcCtD
Fluoxymesterone—Haemorrhage—Methotrexate—psoriasis	5.62e-05	0.00195	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—STAT3—psoriasis	5.61e-05	0.00316	CbGpPWpGaD
Fluoxymesterone—Headache—Mycophenolic acid—psoriasis	5.59e-05	0.00195	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—HLA-E—psoriasis	5.56e-05	0.00313	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—IL6—psoriasis	5.54e-05	0.00312	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—TARS—psoriasis	5.52e-05	0.00311	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Dexamethasone—psoriasis	5.49e-05	0.00191	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Betamethasone—psoriasis	5.49e-05	0.00191	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—CCL20—psoriasis	5.45e-05	0.00307	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Triamcinolone—psoriasis	5.43e-05	0.00189	CcSEcCtD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—JUN—psoriasis	5.35e-05	0.00301	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Cyclosporine—psoriasis	5.32e-05	0.00185	CcSEcCtD
Fluoxymesterone—Nausea—Mycophenolic acid—psoriasis	5.3e-05	0.00184	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Mycophenolate mofetil—psoriasis	5.19e-05	0.00181	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	4.97e-05	0.0028	CbGpPWpGaD
Fluoxymesterone—Anxiety—Prednisone—psoriasis	4.97e-05	0.00173	CcSEcCtD
Fluoxymesterone—Alopecia—Methotrexate—psoriasis	4.97e-05	0.00173	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL10—psoriasis	4.96e-05	0.0028	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Betamethasone—psoriasis	4.93e-05	0.00171	CcSEcCtD
Fluoxymesterone—Paraesthesia—Dexamethasone—psoriasis	4.93e-05	0.00171	CcSEcCtD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IFNG—psoriasis	4.89e-05	0.00276	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—psoriasis	4.87e-05	0.00274	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—SOCS1—psoriasis	4.86e-05	0.00274	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Prednisolone—psoriasis	4.84e-05	0.00168	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Prednisone—psoriasis	4.78e-05	0.00166	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Hydrocortisone—psoriasis	4.73e-05	0.00165	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—SOCS1—psoriasis	4.64e-05	0.00262	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—psoriasis	4.63e-05	0.00261	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—CXCL8—psoriasis	4.55e-05	0.00256	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—JUN—psoriasis	4.54e-05	0.00256	CbGpPWpGaD
Fluoxymesterone—Headache—Cyclosporine—psoriasis	4.53e-05	0.00157	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	4.51e-05	0.00254	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Triamcinolone—psoriasis	4.45e-05	0.00155	CcSEcCtD
Fluoxymesterone—Headache—Mycophenolate mofetil—psoriasis	4.42e-05	0.00154	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of Telomerase—IFNG—psoriasis	4.37e-05	0.00246	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—psoriasis	4.3e-05	0.00243	CbGpPWpGaD
Fluoxymesterone—Nausea—Cyclosporine—psoriasis	4.29e-05	0.00149	CcSEcCtD
Fluoxymesterone—Paraesthesia—Prednisone—psoriasis	4.29e-05	0.00149	CcSEcCtD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IFNG—psoriasis	4.27e-05	0.0024	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	4.26e-05	0.0024	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—TARS—psoriasis	4.25e-05	0.0024	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	4.24e-05	0.00239	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—JUN—psoriasis	4.23e-05	0.00238	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IFNG—psoriasis	4.2e-05	0.00237	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—TARS—psoriasis	4.19e-05	0.00236	CbGpPWpGaD
Fluoxymesterone—Nausea—Mycophenolate mofetil—psoriasis	4.19e-05	0.00146	CcSEcCtD
Fluoxymesterone—Headache—Prednisolone—psoriasis	4.12e-05	0.00143	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—CD8A—psoriasis	4.12e-05	0.00232	CbGpPWpGaD
Fluoxymesterone—Headache—Hydrocortisone—psoriasis	4.02e-05	0.0014	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Methotrexate—psoriasis	3.99e-05	0.00139	CcSEcCtD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CXCL8—psoriasis	3.97e-05	0.00224	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—JUN—psoriasis	3.96e-05	0.00223	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HLA-B—psoriasis	3.96e-05	0.00223	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—JUN—psoriasis	3.95e-05	0.00223	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL6—psoriasis	3.92e-05	0.00221	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CXCL8—psoriasis	3.91e-05	0.0022	CbGpPWpGaD
Fluoxymesterone—Nausea—Prednisolone—psoriasis	3.91e-05	0.00136	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.86e-05	0.00218	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.85e-05	0.00217	CbGpPWpGaD
Fluoxymesterone—Nausea—Hydrocortisone—psoriasis	3.81e-05	0.00133	CcSEcCtD
Fluoxymesterone—Headache—Triamcinolone—psoriasis	3.79e-05	0.00132	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of Telomerase—JUN—psoriasis	3.77e-05	0.00213	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL10—psoriasis	3.76e-05	0.00212	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—psoriasis	3.7e-05	0.00209	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—JUN—psoriasis	3.69e-05	0.00208	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HLA-A—psoriasis	3.67e-05	0.00207	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—NFKB1—psoriasis	3.63e-05	0.00205	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—JUN—psoriasis	3.63e-05	0.00205	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CARM1—psoriasis	3.61e-05	0.00203	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—psoriasis	3.6e-05	0.00203	CbGpPWpGaD
Fluoxymesterone—Nausea—Triamcinolone—psoriasis	3.59e-05	0.00125	CcSEcCtD
Fluoxymesterone—Paraesthesia—Methotrexate—psoriasis	3.59e-05	0.00125	CcSEcCtD
Fluoxymesterone—NR3C1—Adipogenesis—LEP—psoriasis	3.58e-05	0.00202	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Prednisone—psoriasis	3.52e-05	0.00122	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—CRP—psoriasis	3.5e-05	0.00197	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	3.44e-05	0.00194	CbGpPWpGaD
Fluoxymesterone—Headache—Betamethasone—psoriasis	3.44e-05	0.0012	CcSEcCtD
Fluoxymesterone—Headache—Dexamethasone—psoriasis	3.44e-05	0.0012	CcSEcCtD
Fluoxymesterone—AR—Androgen receptor signaling pathway—STAT3—psoriasis	3.42e-05	0.00193	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—NFKB1—psoriasis	3.36e-05	0.00189	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HLA-DRB1—psoriasis	3.35e-05	0.00189	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	3.28e-05	0.00185	CbGpPWpGaD
Fluoxymesterone—Nausea—Betamethasone—psoriasis	3.26e-05	0.00113	CcSEcCtD
Fluoxymesterone—Nausea—Dexamethasone—psoriasis	3.26e-05	0.00113	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.24e-05	0.00182	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	3.23e-05	0.00182	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ICAM1—psoriasis	3.22e-05	0.00181	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—JUN—psoriasis	3.2e-05	0.0018	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NFKBIA—psoriasis	3.19e-05	0.0018	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—PPARG—psoriasis	3.12e-05	0.00176	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	3.08e-05	0.00174	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—STAT3—psoriasis	3.02e-05	0.0017	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SOCS1—psoriasis	3e-05	0.00169	CbGpPWpGaD
Fluoxymesterone—Headache—Prednisone—psoriasis	2.99e-05	0.00104	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.97e-05	0.00167	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Methotrexate—psoriasis	2.94e-05	0.00102	CcSEcCtD
Fluoxymesterone—Nausea—Prednisone—psoriasis	2.84e-05	0.000987	CcSEcCtD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CARM1—psoriasis	2.78e-05	0.00157	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CARM1—psoriasis	2.74e-05	0.00154	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.71e-05	0.00153	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—TYK2—psoriasis	2.61e-05	0.00147	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—JUN—psoriasis	2.59e-05	0.00146	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL6—psoriasis	2.56e-05	0.00144	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—JUN—psoriasis	2.52e-05	0.00142	CbGpPWpGaD
Fluoxymesterone—Headache—Methotrexate—psoriasis	2.5e-05	0.00087	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.49e-05	0.0014	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—NFKB1—psoriasis	2.49e-05	0.0014	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—TYK2—psoriasis	2.45e-05	0.00138	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IFNG—psoriasis	2.45e-05	0.00138	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—psoriasis	2.43e-05	0.00137	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.43e-05	0.00137	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—psoriasis	2.4e-05	0.00135	CbGpPWpGaD
Fluoxymesterone—Nausea—Methotrexate—psoriasis	2.37e-05	0.000825	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—CD4—psoriasis	2.36e-05	0.00133	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—psoriasis	2.26e-05	0.00127	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL6—psoriasis	2.23e-05	0.00126	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—LEP—psoriasis	2.21e-05	0.00125	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOE—psoriasis	2.21e-05	0.00125	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.2e-05	0.00124	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—psoriasis	2.19e-05	0.00124	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—VDR—psoriasis	2.15e-05	0.00121	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.14e-05	0.00121	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—JUN—psoriasis	2.12e-05	0.00119	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—psoriasis	2.11e-05	0.00119	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.06e-05	0.00116	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NFKBIA—psoriasis	2.06e-05	0.00116	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.06e-05	0.00116	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NFKB1—psoriasis	2.04e-05	0.00115	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—JUN—psoriasis	1.99e-05	0.00112	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HCAR2—psoriasis	1.97e-05	0.00111	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—psoriasis	1.93e-05	0.00109	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	1.92e-05	0.00108	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—STAT3—psoriasis	1.91e-05	0.00108	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—JUN—psoriasis	1.91e-05	0.00108	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—psoriasis	1.89e-05	0.00106	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.87e-05	0.00106	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—NFKB1—psoriasis	1.84e-05	0.00104	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—STAT3—psoriasis	1.83e-05	0.00103	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	1.74e-05	0.000982	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CARM1—psoriasis	1.74e-05	0.000979	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—psoriasis	1.71e-05	0.000963	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TAGAP—psoriasis	1.71e-05	0.000963	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TYK2—psoriasis	1.69e-05	0.000953	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.67e-05	0.000942	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—VDR—psoriasis	1.66e-05	0.000936	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—psoriasis	1.66e-05	0.000934	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.65e-05	0.000931	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—VDR—psoriasis	1.63e-05	0.000921	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.61e-05	0.000905	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.59e-05	0.000896	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—psoriasis	1.52e-05	0.000859	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARG—psoriasis	1.5e-05	0.000847	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL8—psoriasis	1.47e-05	0.00083	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.44e-05	0.000814	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—psoriasis	1.43e-05	0.000807	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.42e-05	0.000798	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—JUN—psoriasis	1.37e-05	0.000771	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CARM1—psoriasis	1.34e-05	0.000754	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—psoriasis	1.34e-05	0.000754	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CARM1—psoriasis	1.32e-05	0.000743	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NFKB1—psoriasis	1.32e-05	0.000742	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—psoriasis	1.32e-05	0.000742	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—psoriasis	1.28e-05	0.000721	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.24e-05	0.000697	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—psoriasis	1.2e-05	0.000675	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—psoriasis	1.2e-05	0.000674	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT3—psoriasis	1.18e-05	0.000667	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARG—psoriasis	1.16e-05	0.000652	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—psoriasis	1.16e-05	0.000652	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARG—psoriasis	1.14e-05	0.000642	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.09e-05	0.000615	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—VDR—psoriasis	1.04e-05	0.000585	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL20—psoriasis	1.02e-05	0.000577	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—psoriasis	9.03e-06	0.000509	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—psoriasis	8.27e-06	0.000466	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—VDR—psoriasis	7.99e-06	0.00045	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—VDR—psoriasis	7.87e-06	0.000444	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARG—psoriasis	7.23e-06	0.000408	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SOCS1—psoriasis	5.64e-06	0.000318	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARG—psoriasis	5.57e-06	0.000314	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARG—psoriasis	5.49e-06	0.000309	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LEP—psoriasis	4.16e-06	0.000234	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOE—psoriasis	4.16e-06	0.000234	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NFKBIA—psoriasis	3.88e-06	0.000218	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TYK2—psoriasis	3.17e-06	0.000179	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL8—psoriasis	2.76e-06	0.000156	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JUN—psoriasis	2.57e-06	0.000145	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NFKB1—psoriasis	2.47e-06	0.000139	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—psoriasis	2.24e-06	0.000127	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT3—psoriasis	2.22e-06	0.000125	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—psoriasis	1.7e-06	9.56e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—psoriasis	1.55e-06	8.75e-05	CbGpPWpGaD
